• 12163 Citations
  • 52 h-Index
1989 …2020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Perrone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2020

Denosumab in early breast cancer: negative data and a call to action

Perrone, F. & Gravina, A., Jan 2020, In : The Lancet Oncology. 21, 1, p. 5-6 2 p.

Research output: Contribution to journalComment/debate

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018

Reale, M. L., De Luca, E., Lombardi, P., Marandino, L., Zichi, C., Pignataro, D., Ghisoni, E., Di Stefano, R. F., Mariniello, A., Trevisi, E., Leone, G., Muratori, L., La Salvia, A., Sonetto, C., Bironzo, P., Aglietta, M., Novello, S., Scagliotti, G. V., Perrone, F. & Di Maio, M., Jan 2020, In : Lung Cancer. 139, p. 47-54 8 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., Sep 1 2019, In : European Journal of Cancer. 118, p. 178-186 9 p.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., 2019, In : European Journal of Cancer.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy

Trotta, F., Mayer, F., Barone-Adesi, F., Esposito, I., Punreddy, R., Da Cas, R., Traversa, G., Perrone, F., Martini, N., Gyawali, B. & Addis, A., Dec 10 2019, In : BMJ Open. 9, 12, p. e033728

Research output: Contribution to journalArticle

Open Access